Product Details
C-Reactive Protein / Serum Amyloid Protein Combined
Reagent(CRP/SAA)Clinical comparison
Combined detection of CRP and SAA
In recent years, based on the clinical value of white blood cell
(WBC) + C-reactive protein (CRP) + serum amyloid A (SAA) detection
in the diagnosis of infantile infection, many famous pediatric
experts have proposed "three new routine tests", namely, white
blood cell (WBC) + C-reactive protein (CRP) + serum amyloid A
(SAA). It has been widely used and recognized. The results showed
that the total positive rate of SAA in various inflammatory
diseases was 8.54% higher than that of CRP. Combined SAA and CRP
test can more accurately diagnose the type of infection and monitor
the course of infection
CRP / SAA performance index
Detection range | sample size | Sample type | Test time |
CRP | SAA | 5μl | Whole blood / serum / plasma | 3min |
0.5~200mg/L | 5~200mg/L |
Clinical significance of CRP / SAA
SAA normal CRP was normal | SAA normal Elevated CRP | SAA increased CRP was normal | SAA increased Elevated CRP |
Consider non-infectious factors | The disease is improving | Consider virus infection | Consider bacterial infection |
Continue treatment based on clinical symptoms or continue to
monitor SAA and CRP until they return to normal | Continue treatment based on clinical symptoms or continue to
monitor SAA and CRP to return to normal | Antiviral treatment; monitor SAA and CRP to return to normal or
consider changing the treatment plan | Antibiotic treatment, monitor SAA and CRP to return to normal or
consider changing the treatment plan |
- Local bacterial and viral infections were found.
- Early diagnosis of infectious diseases in children
- Effective assessment of the severity of viral infection.
Application Department
Laboratory, infection, fever clinic, pediatrics, cardiology, organ
transplantation, etc
Clinical comparison of CRP / SAA
Company profile
Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise
engaged in the research and development, production and operation
of in vitro diagnostic products. The in vitro diagnostic products
developed by the company cover POCT series, microbial series,
biochemical series and immune series reagents and supporting
instruments.
The company has always adhered to the core concept of "fast and
accurate, living up to life", committed to providing society with
excellent products and services, and contributing to the cause of
human health.
Company Profile
Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is
located in Dingluan Industrial Zone, Changyuan City, Henan
Province. The company covers an area of about 100 acres and the
initial investment is about 200 million yuan. The company has a
scientific and complete management system, a purification workshop
of national standards, and a fully functional inspection center. On
this basis, the company will continue to invest in research and
development, accumulate technical strength, update manufacturing
equipment, improve production technology, improve inspection
technology, improve product quality, and provide customers with
safe and effective in vitro diagnostic products.
Zhongxiu Science And Technology Co., Ltd. is a high-tech enterprise
engaged in the research and development, production and operation
of in vitro diagnostic products. The in vitro diagnostic products
developed by the company cover POCT series, immune series,
microbial series and other reagents and supporting instruments.
The company has always adhered to the core concept of “fast and
accurate, living up to life”, committed to providing society with
excellent products and services, and contributing to the cause of
human health.